167 related articles for article (PubMed ID: 21752182)
1. Accelerating the development of improved analgesic treatments: the ACTION public-private partnership.
Dworkin RH; Turk DC
Pain Med; 2011 Jul; 12 Suppl 3():S109-17. PubMed ID: 21752182
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
Katz J; Finnerup NB; Dworkin RH
Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
5. Early phase drug development for treatment of chronic pain--options for clinical trial and program design.
Kalliomäki J; Miller F; Kågedal M; Karlsten R
Contemp Clin Trials; 2012 Jul; 33(4):689-99. PubMed ID: 22401888
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant analgesics in neuropathic pain.
Kong VK; Irwin MG
Eur J Anaesthesiol; 2009 Feb; 26(2):96-100. PubMed ID: 19142081
[TBL] [Abstract][Full Text] [Related]
7. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.
Dworkin RH; Turk DC; Peirce-Sandner S; Burke LB; Farrar JT; Gilron I; Jensen MP; Katz NP; Raja SN; Rappaport BA; Rowbotham MC; Backonja MM; Baron R; Bellamy N; Bhagwagar Z; Costello A; Cowan P; Fang WC; Hertz S; Jay GW; Junor R; Kerns RD; Kerwin R; Kopecky EA; Lissin D; Malamut R; Markman JD; McDermott MP; Munera C; Porter L; Rauschkolb C; Rice ASC; Sampaio C; Skljarevski V; Sommerville K; Stacey BR; Steigerwald I; Tobias J; Trentacosti AM; Wasan AD; Wells GA; Williams J; Witter J; Ziegler D
Pain; 2012 Jun; 153(6):1148-1158. PubMed ID: 22494920
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
Ashton JC; Milligan ED
Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based postoperative pain management in nursing: is a randomized-controlled trial the most appropriate design?
Seers K; Crichton N; Carroll D; Richards S; Saunders T
J Nurs Manag; 2004 May; 12(3):183-93. PubMed ID: 15089956
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. [Novel potential uses of thalidomide in the management of pain? A review of the literature].
Peuckmann V; Strumpf M; Zenz M; Bruera E
Schmerz; 2003 Jun; 17(3):204-10. PubMed ID: 12789488
[TBL] [Abstract][Full Text] [Related]
12. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
13. Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
Edelsberg J; Oster G
Eur J Pain; 2009 Jan; 13(1):11-6. PubMed ID: 18456524
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
15. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Trials Transformation Initiative (CTTI).
Grignolo A
Ann Ist Super Sanita; 2011; 47(1):14-8. PubMed ID: 21430332
[TBL] [Abstract][Full Text] [Related]
17. ACTION on the prevention of chronic pain after surgery: public-private partnerships, the future of analgesic drug development.
Rappaport BA; Cerny I; Sanhai WR
Anesthesiology; 2010 Mar; 112(3):509-10. PubMed ID: 20124974
[No Abstract] [Full Text] [Related]
18. What can chronic arthritis pain teach about developing new analgesic drugs?
Witter J; Dionne RA
Arthritis Res Ther; 2004; 6(6):279-81. PubMed ID: 15535840
[TBL] [Abstract][Full Text] [Related]
19. Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials.
Rothman M; Vallow S; Damaraju CV; Hewitt DJ
Curr Med Res Opin; 2009 Jun; 25(6):1433-43. PubMed ID: 19419336
[TBL] [Abstract][Full Text] [Related]
20. Preliminary observations of a novel topical oil with analgesic properties for treatment of acute and chronic pain syndromes.
Pergolizzi JV; Pappagallo M; Raffa RB; Gharibo C; Phillips RB; Desjonquères S; Tabor A
Pain Pract; 2010; 10(3):201-13. PubMed ID: 20230451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
